<DOC>
	<DOC>NCT00304213</DOC>
	<brief_summary>This is a randomized controlled trial of testosterone replacement therapy in hypogonadal men age &gt; 60 years. The goal is to assess the safety and efficacy of TRT in men age &gt; 60 years.</brief_summary>
	<brief_title>Does Testosterone Improve Function in Hypogonadal Older Men</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>age 6080 yrs serum total testosterone &lt; 300 ng/dL serum bioavailable testosterone &lt; 70 ng/dL unable to provide informed consent history of prostate or breast cancer untreated sleep apnea</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>testosterone</keyword>
	<keyword>aging</keyword>
	<keyword>Total testosterone &lt; 300 ng/dL</keyword>
	<keyword>Bioavailable testosterone &lt; 70 ng/dL</keyword>
</DOC>